Literature DB >> 21085195

Air-assisted intranasal instillation enhances adenoviral delivery to the olfactory epithelium and respiratory tract.

P Gau1, S Rodriguez, C De Leonardis, P Chen, D M Lin.   

Abstract

Intranasal instillation is used to deliver adenoviral vectors to the olfactory epithelium and respiratory tract. The success of this approach, however, has been tempered by inconsistent infectivity in both the epithelium and lungs. Infection of the epithelium may be hampered in part by the convoluted structure of the cavity, the presence of mucus or poor airflow in the posterior cavity. Delivery of adenovirus to the lungs can be uneven in the various lobes and distal bronchioles may be poorly infected. Current approaches to circumvent these issues rely principally on intubation or intratracheal instillation. Here we describe a technique that significantly improves adenoviral infectivity rates without requiring surgical intervention. We use compressed air to increase circulation of instilled adenovirus, resulting in enhanced infection in both the epithelium and lungs. This procedure is straightforward, simple to perform and requires no specialized equipment. In the epithelium, neurons and sustentacular cells are both labeled. In the lungs, all lobes can be infected, with penetration to the most distal bronchioles. The use of compressed air will likely also be useful for enhancing the distribution of other, desired agents within the epithelium, central nervous system and respiratory tract.

Entities:  

Mesh:

Year:  2010        PMID: 21085195      PMCID: PMC3509198          DOI: 10.1038/gt.2010.153

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  25 in total

1.  Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia.

Authors:  D S Southam; M Dolovich; P M O'Byrne; M D Inman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-04       Impact factor: 5.464

2.  Adenoviral vector-mediated expression of B-50/GAP-43 induces alterations in the membrane organization of olfactory axon terminals in vivo.

Authors:  A J Holtmaat; W T Hermens; M A Sonnemans; R J Giger; F W Van Leeuwen; M G Kaplitt; A B Oestreicher; W H Gispen; J Verhaagen
Journal:  J Neurosci       Date:  1997-09-01       Impact factor: 6.167

Review 3.  Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

Authors:  Shyeilla V Dhuria; Leah R Hanson; William H Frey
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

Review 4.  Nasal route for direct delivery of solutes to the central nervous system: fact or fiction?

Authors:  S Mathison; R Nagilla; U B Kompella
Journal:  J Drug Target       Date:  1998       Impact factor: 5.121

5.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

6.  Functional expression of a mammalian odorant receptor.

Authors:  H Zhao; L Ivic; J M Otaki; M Hashimoto; K Mikoshiba; S Firestein
Journal:  Science       Date:  1998-01-09       Impact factor: 47.728

7.  Use of ultrasound to enhance nonviral lung gene transfer in vivo.

Authors:  S Xenariou; U Griesenbach; H-D Liang; J Zhu; R Farley; L Somerton; C Singh; P K Jeffery; S Ferrari; R K Scheule; S H Cheng; D M Geddes; M Blomley; E W F W Alton
Journal:  Gene Ther       Date:  2007-02-15       Impact factor: 5.250

8.  Phospholipid-induced in vivo particle migration to enhance pulmonary deposition.

Authors:  Sudipta Ganguly; Vikas Moolchandani; Joseph A Roche; Paul S Shapiro; Shailaja Somaraju; Natalie D Eddington; Richard N Dalby
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2008-12       Impact factor: 2.849

9.  Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo.

Authors:  A Fasbender; J H Lee; R W Walters; T O Moninger; J Zabner; M J Welsh
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

10.  Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system.

Authors:  Shyeilla V Dhuria; Leah R Hanson; William H Frey
Journal:  J Pharm Sci       Date:  2009-07       Impact factor: 3.534

View more
  6 in total

Review 1.  Olfactory Loss and Dysfunction in Ciliopathies: Molecular Mechanisms and Potential Therapies.

Authors:  Cedric R Uytingco; Warren W Green; Jeffrey R Martens
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

2.  A long-lasting, single-dose nasal vaccine for Ebola: a practical armament for an outbreak with significant global impact.

Authors:  Kristina Jonsson-Schmunk; Maria A Croyle
Journal:  Expert Rev Anti Infect Ther       Date:  2015-03-23       Impact factor: 5.091

Review 3.  Smelling the roses and seeing the light: gene therapy for ciliopathies.

Authors:  Jeremy C McIntyre; Corey L Williams; Jeffrey R Martens
Journal:  Trends Biotechnol       Date:  2013-04-17       Impact factor: 19.536

4.  p21 both attenuates and drives senescence and aging in BubR1 progeroid mice.

Authors:  Darren J Baker; Robbyn L Weaver; Jan M van Deursen
Journal:  Cell Rep       Date:  2013-04-18       Impact factor: 9.423

5.  Transduction of ferret airway epithelia using a pre-treatment and lentiviral gene vector.

Authors:  Patricia Cmielewski; Nigel Farrow; Martin Donnelley; Chantelle McIntyre; Jahan Penny-Dimri; Tim Kuchel; David Parsons
Journal:  BMC Pulm Med       Date:  2014-11-21       Impact factor: 3.317

6.  Aβ alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo.

Authors:  Luxiang Cao; Benjamin R Schrank; Steve Rodriguez; Eric G Benz; Thomas W Moulia; Gregory T Rickenbacher; Alexis C Gomez; Yona Levites; Sarah R Edwards; Todd E Golde; Bradley T Hyman; Gilad Barnea; Mark W Albers
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.